PUBLIC COMPANY
saveNeuren Pharmaceuticals Ltd
updated 2mo ago
community read0 votes
pipeline
1
marketed
0
phase 3
1
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(1)
pipeline depth1 products
1Phase 3
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
- phase3A Study of NNZ-2591 in Pediatric Participants With Phelan-McDermid Syndrome
- phase3An Open-label Study of NNZ-2591 in Pediatric Participants With Phelan-McDermid Syndrome
- phase2An Open-Label Study of Oral NNZ-2591 in Pitt Hopkins Syndrome (PTHS-001)
- phase2An Open-Label Study of Oral NNZ-2591 in Phelan-McDermid Syndrome (PMS-001)
- phase2An Open-Label Study of the Safety, Tolerability, and Pharmacokinetics of Oral NNZ-2591 in Angelman Syndrome
- phase2An Open-Label Study of Oral NNZ-2591 in Prader-Willi Syndrome (PWS-001)
🐶 Hiring Signal
News
no news has mentioned this company yet
comments(0)
5-min edit window · permanent after that